Clinical Trials · NCT00003653

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
NCIC Clinical Trials Group
Enrollment
1,386
Start date
Jan 1999
Locations
29 sites, Canada
Primary endpoint
Overall survival
View Gonadorelin compound reference